Compare AbbVie Inc (ABBV) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs Alliant Energy Corporation — how do they compare? AbbVie Inc trades at $253.68 (market cap $449.91B), while Alliant Energy Corporation trades at $76.39 (market cap $20.06B). The key difference: AbbVie Inc is far larger — about 22.4× Alliant Energy Corporation's market cap, and AbbVie Inc pays the higher dividend (2.72%). Which is the better fit depends on your goals.
| ABBV | LNT | |
|---|---|---|
Market Cap | $449.91B | $20.06B |
Sector | Health | Utilities |
52-Week High | $261.07 | $78.03 |
52-Week Low | $184.85 | $61.26 |
Enterprise Value | $513.38B | $31.78B |
Dividend Yield | 2.72% | 2.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $252.92, down 0.72% on the day, with strong technical support at $251 and resistance at $258. The stock shows bullish momentum with recent earnings beats and a consensus analyst price target of $266.33. Revenue grew to $61.16B in 2025, though net margins compressed to 5.79%. Key growth drivers include Skyrizi and Rinvoq offsetting Humira declines, supported by positive Phase 2 data for ELAHERE in ovarian cancer (PRNewsWire, 2026-04-12).
Outlook remains positive with immunology portfolio strength and dividend growth, but risks include patent cliffs in the 2030s and high debt levels. Institutional buying and 68% analyst buy ratings suggest confidence, though valuation multiples like P/E of 124.83 warrant caution. Near-term catalysts include Q2 2026 earnings expected at $3.79 EPS.
LNT trades at $77.65, down 0.49% on the day, with a bullish technical signal from moving averages and key resistance at $78. The company reported revenue of $4.36B in 2025 with net income of $810M, and recent quarters show mixed earnings performance against estimates. A $13.4B investment plan supports growth in data center demand and clean energy expansion, while analyst consensus is a Buy with a $75.67 price target.
LNT offers steady utility earnings growth and a dividend yield, but faces risks from rising debt levels and interest expenses. The stock's valuation multiples are above sector averages, requiring continued execution on capital investments to justify premium pricing amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
